Citizens Jmp Cuts NSRX (NYSEAMERICAN:NSRX) Price Target to $18.00

NSRX (NYSEAMERICAN:NSRX) had its target price trimmed by Citizens Jmp from $19.00 to $18.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a market outperform rating on the stock.

NSRX Stock Down 7.9%

Shares of NYSEAMERICAN:NSRX opened at $2.21 on Thursday. NSRX has a 12 month low of $2.14 and a 12 month high of $9.99. The firm has a 50-day simple moving average of $4.91.

NSRX Company Profile

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.